...PIK3CA. Additional expression profiling highlight that LINC00520 is elevated in a subset of human breast carcinomas, wit...
...PIK3CA and APC) of MCF7 cells were evaluated in the isolated samples. The results showed that somatic mutations could be...
...PIK3CA, AKT1, KRAS, NRAS, and BRAF in order to select patients for targeted therapy clinical trials. The genomes of arch...
...PIK3CA mutant), the MCF7 and HBCx-2 breast cancer models and the AKT mutant driven prostate cancer (LAPC-4) and anal can...
...PIK3CA [odds ratio (OR) = 0.42, P = 0.0185]. Mutations in 33 of 714 pathways were significantly associated with response...
...PIK3CA mutations were associated with markedly decreased tumoral PD-L1 expression, LUSCs with PIK3CA mutations exhibited...
...PIK3CA mutations were predictive of poor response to adjuvant therapy. Immune marker analysis revealed that LUADs in smo...
...PIK3CA mutations. Over a 4-year follow-up period, structurally identifiable bone metastases were persistent, but serial ...
...PIK3CA and a focal deletion of the chromosomal region 1p32. We identify pterostilbene-induced cell cycle arrest, synergi...
...PIK3CA, PTEN, EGFR, and ERBB2. We also identified other targetable GA, including novel kinase fusions, receptor tyrosine...
联系地址
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话： 0531-88819269
版权所有 © 2025.Genelibs 济南弘晖生物技术有限公司 鲁ICP备20007159号-2
